Takeda to divest select APAC assets to Celltrion for $278M

Japanese firm Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a...

June 15, 2020 | Monday | News
AbbVie, Genmab enter $4B cancer immunotherapy partnership

US-based AbbVie and Genmab announced on 10 June 2020 that they had formed the partnership that will focus on b...

June 11, 2020 | Thursday | News
Fujifilm to invest 100B yen at Denmark site

Japanese multinational firm FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (...

June 12, 2020 | Friday | News
Eisai takes Counter-Measures to tackle COVID-19 spread in Africa

Eisai Co., Ltd. announced on 10 June 2020 that it has committed the equivalent of 1 million USD in aid towards various a...

June 10, 2020 | Wednesday | News
Japan explores Nafamostat inhalation formulation for COVID-19 treatment

The University of Tokyo, RIKEN, Nichi-Iko Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited have reached a ba...

June 10, 2020 | Wednesday | News
Healthtech startup Ubie raises $18.7M in Series B financing

Ubie, a Tokyo based HealthTech startup who is the developer of AI-based healthcare products, has raised JPY2 billio...

June 9, 2020 | Tuesday | News
Healios establishes proprietary universal donor cell research line

Healios K.K., Japan's leading clinical-stage biotechnology company, has been creating Universal Donor Cells (U...

June 8, 2020 | Monday | News
Daiichi Sankyo inks clinical research collaboration with Merck

Japan based Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement ...

June 4, 2020 | Thursday | News
Eisai unveils new insomnia drug DAYVIGO

Japan based Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has launched its in-house discovered orexi...

June 3, 2020 | Wednesday | News
NCC Japan joins Illuminox Alliance Institutes network

US based Rakuten Medical, Inc., a global biotechnology company developing precision, cell-targeting investigational ther...

June 2, 2020 | Tuesday | News
Astellas receives approval for prostate cancer drug

Japanese firm Astellas Pharma Inc. has announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has approv...

June 1, 2020 | Monday | News
Shinshu University, Toshiba develop tumor-tropic liposome technology

Japan based Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu Unive...

May 29, 2020 | Friday | News
Takeda focuses on potential new therapies for COVID-19

Japanese firm Takeda Pharmaceutical Company Limited is a key leader of a coalition who has announced that world-leading ...

May 28, 2020 | Thursday | News
Daiichi Sankyo launches novel oncology medicine in Japan

Japanese firm Daiichi Sankyo Company, Limited has announced the launch of ENHERTU® (trastuzumab deruxtecan), a HER2 ...

May 27, 2020 | Wednesday | News
Fujifilm to use AI-based technology for COVID-19 diagnosis

Japan based FUJIFILM Corporation is commencing a research study to develop Artificial Intelligence (AI)-based technology...

May 26, 2020 | Tuesday | News
Cytiva, Takara Bio to scale up COVID-19 vaccine candidate

Cytiva (formerly part of GE Healthcare Life Sciences), a global provider of technologies and services that advance and a...

May 21, 2020 | Thursday | News
AGC Biologics partners with Takara Bio in COVID-19 fight

Denmark headquartered AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmace...

May 22, 2020 | Friday | News
Eisai to launch new Selbelle Premium Tablets and Fine Granules

Japan based Eisai Co., Ltd. announced that it has launched New Selbelle Premium Tablets and New Selbelle Premium Fine Gr...

May 19, 2020 | Tuesday | News